Cargando…
ADAR expression and copy number variation in patients with advanced gastric cancer
BACKGROUND: Gastric cancer (GC) is a world health problem and it is the third leading cause of cancer deaths worldwide. The current practice for prognosis assessment in GC is based on radiological and pathological criteria and they may not result in an accurate prognosis. The aim of this study is to...
Autores principales: | Behroozi, Javad, Shahbazi, Shirin, Bakhtiarizadeh, Mohammad Reza, Mahmoodzadeh, Habibollah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227226/ https://www.ncbi.nlm.nih.gov/pubmed/32410589 http://dx.doi.org/10.1186/s12876-020-01299-8 |
Ejemplares similares
-
Genome-Wide Characterization of RNA Editing Sites in Primary Gastric Adenocarcinoma through RNA-seq Data Analysis
por: Behroozi, Javad, et al.
Publicado: (2020) -
MYC, FBXW7 and TP53 copy number variation and expression in Gastric Cancer
por: Calcagno, Danielle Queiroz, et al.
Publicado: (2013) -
Copy number variations and cancer
por: Shlien, Adam, et al.
Publicado: (2009) -
Mitochondrial DNA Copy Number Variations and Serum Pepsinogen Levels for Risk Assessment in Gastric Cancer
por: Alikhani, Mehdi, et al.
Publicado: (2021) -
Advanced maternal age: copy number variations and pregnancy outcomes
por: Cao, Luoyuan, et al.
Publicado: (2023)